Gram-negative bacterial virulence factors

Gram-negative bacterial virulence factors are a diverse group of molecules and structures produced by pathogens like Pseudomonas aeruginosa and Escherichia coli to facilitate host colonization and disease progression [1]. These factors include structural elements such as lipopolysaccharides (LPS) and fimbriae, as well as secreted proteins like exotoxins and siderophores [2]. A hallmark of many Gram-negative pathogens is the use of complex secretion systems, such as the Type III secretion system (T3SS), which acts as a molecular syringe to inject effector proteins directly into host cells to subvert immune responses [3]. Unlike traditional antibiotics that target essential survival processes, anti-virulence therapies aim to disarm the bacteria, thereby reducing tissue damage and allowing the host immune system to clear the infection [4]. This approach is particularly valuable for addressing multi-drug resistant (MDR) strains, as it may impose less selective pressure for the development of resistance compared to bactericidal agents [5]. Citations: [1] https://www.nature.com/articles/nrmicro.2017.86 [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC6600117/ [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1195961/ [4] https://www.frontiersin.org/articles/10.3389/fmicb.2019.02862/full [5] https://pubmed.ncbi.nlm.nih.gov/28434881/

Other names

Virulence determinantsPathogenicity factorsBacterial effectorsVirulence-associated proteins

Neutralization of toxins, inhibition of bacterial adhesion, blockade of secretion systems, and disruption of quorum sensing.